Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now shows the trial’s updated results status and reporting timeline, including a new “Results Posted” date (2026-04-22) and updated results reporting entries. It also adds/updates the defined outcome measures and their accompanying methodology text for efficacy (ORR, PFS, OS), safety (treatment-related toxicities graded by CTCAE v5.0), and exploratory biomarker analyses.SummaryDifference2%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedVersion bump from v3.4.3 to v3.5.0; no changes to study details or patient-facing information.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded a new publication citation for NCI9673 Part B (J Clin Oncol 2026; 44(6):497-507) to Publications.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.4.2; removed the prior government funding status notice and Revision: v3.4.1, reflecting an administrative update to the site header.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.